GoAI
Get started
CDT Equity Inc. logo

CDT Equity Inc.

CDT

NASDAQHealthcareBiotechnology

Open in GoAI

Previous close

$2.86

−$0.04 · -1.38%

Aug 21, 4:00 PM ET

CDT company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

46

Fair Value

Momentum

17

Strong Down

Sentiment

55

Mixed

Risk resilience

27

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Based in Naples, Florida, CDT Equity, Inc. commenced operations in October 2021. This firm, co-founded by David Joszef Tapolczay and Freda C. Lewis-Hall, focuses on aiding the advancement and market entry of clinical-stage medical innovations.

Industry
Biotechnology
Sector
Healthcare
Headquarters
US
CEO
Andrew Regan
Listed since
Mar 28, 2022
Employees
4

Market position

Day range

Current $2.86

52-week range

Current $2.86

Open
$2.99
Previous close
$2.90
Volume
81.26K
0.11× average
Average volume
717.97K
Average daily volume
Market cap
1.39M USD
Beta
1.49
Market reference 1
50-day average
$4.6686
-38.74% below average
200-day average
$172.81
-98.35% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
1B USD
P/E (TTM)
0.04×
P/B (TTM)
0.08×
P/S (TTM)
0×
EV / EBITDA
-27.48×
Earnings yield
-36.81%
Free cash flow yield
-16.85%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
38.65%
Operating margin
11.55%
Net margin
6.30%
Return on equity
-3.10%
Return on assets
-1.11%
Return on invested capital
-1.29%

Financial health

Debt / equity
0.95×
Current ratio
1.93×
Altman Z-score
1.44
Piotroski F-score
7 of 9

Financial statements

Income trends

Operating income

−36.76M USD-138.39%

Net income

−39.22M USD-120.33%
Income trends across reported periods3.33M USD−12.14M USD−27.62M USD−43.09M USDOperating income, FY2021: −3.17M USDOperating income, FY2022: −3.16M USDOperating income, FY2023: −5.26M USDOperating income, FY2024: −15.42M USDOperating income, FY2025: −36.76M USDNet income, FY2021: −3.66M USDNet income, FY2022: −4.89M USDNet income, FY2023: −535K USDNet income, FY2024: −17.8M USDNet income, FY2025: −39.22M USDFY2021FY2022FY2023FY2024FY2025
Operating income FY2021 −3.17M USD. Operating income FY2022 −3.16M USD. Operating income FY2023 −5.26M USD. Operating income FY2024 −15.42M USD. Operating income FY2025 −36.76M USD. Net income FY2021 −3.66M USD. Net income FY2022 −4.89M USD. Net income FY2023 −535K USD. Net income FY2024 −17.8M USD. Net income FY2025 −39.22M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Research and development5.05M USD3.38M USD90K USD111K USD283K USD
Selling, general, and administrative31.7M USD12.04M USD5.17M USD3.05M USD2.89M USD
Operating expenses36.76M USD15.42M USD5.26M USD3.16M USD3.17M USD
Interest income28K USD13K USD15K USD1.98M USD—
Interest expense319K USD1.51M USD211K USD——
Depreciation and amortization2.43M USD457K USD———
Operating income−36.76M USD−15.42M USD−5.26M USD−3.16M USD−3.17M USD
Net income−39.22M USD−17.8M USD−535K USD−4.89M USD−3.66M USD

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
-8.71

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates-0.47-21,945.73-43,890.98-65,836.24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q2 '26Q3 '26Q3 '26
Q4 2024, reported Nov 14, 2024: actual -20,989.51, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 28, 2025: actual -60,959.52, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 15, 2025: actual -3,958.02, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 14, 2025: actual -1,092, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 13, 2025: actual -329, estimate —, surprise —, Comparison unavailable. Q2 2026, reported Apr 3, 2026: actual -231.44, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Jul 15, 2026: actual -0.556, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 12, 2026: actual -8.71, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly Revenue actual values compared with estimates780.16M742.23M704.3M666.37MQ3 '26Q3 '26
Q3 2026, reported Jul 15, 2026: actual 696.38M USD, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 12, 2026: actual 750.16M USD, estimate —, surprise —, Comparison unavailable.

CDT news

globenewswire.com

CDT Increases Stake in Sarborg following its Quantum Computing and Intellectual Property Expansion

NAPLES, Fla. and CAMBRIDGE, United Kingdom, Aug. 03, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) today announced that it has entered into a strategic transaction to increase its equity…

Read source
globenewswire.com

CDT Environmental Technology Announces Results of Extraordinary General Meeting

SHENZHEN, China, July 28, 2026 (GLOBE NEWSWIRE) -- CDT Environmental Technology Investment Holdings Limited (Nasdaq: CDTG) (“CDT”, the “Company”, or “we”), a leading provider of waste treatment systems and services…

Read source
globenewswire.com

CDT Highlights Sarborg's Patent Filing Extending Quantum-Enabled PRISM Platform to Sugarcane

NAPLES, Fla. and CAMBRIDGE, United Kingdom, July 20, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today notes the announcement from Sarborg Limited regarding the filing of a new patent…

Read source
globenewswire.com

CDT Equity Inc. Announces Reverse Stock Split

NAPLES, Fla. and CAMBRIDGE, United Kingdom, July 16, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), announces that its board of directors has approved a 1-for-10 reverse stock split of…

Read source
globenewswire.com

CDT Environmental Technology Investment Holdings Regains Compliance with Nasdaq Minimum Bid Price Requirement

SHENZHEN, China, July 07, 2026 (GLOBE NEWSWIRE) -- CDT Environmental Technology Investment Holdings Limited (NASDAQ: CDTG) (the “Company” or “CDT”), a leading provider of waste treatment systems and services throughout…

Read source
globenewswire.com

CDT Environmental Technology Investment Holdings Limited to Hold Extraordinary General Meeting on July 28, 2026

SHENZHEN, China, July 06, 2026 (GLOBE NEWSWIRE) -- CDT Environmental Technology Investment Holdings Limited (NASDAQ: CDTG) (the “Company” or “CDT”), a leading provider of waste treatment systems and services throughout…

Read source

Corporate actions

Corporate action history

Stock split

Effective Jul 20, 2026

1:10

Stock split

Effective Mar 27, 2026

1:25

Stock split

Effective Oct 13, 2025

1:8

Stock split

Effective May 20, 2025

1:15

Stock split

Effective Jan 27, 2025

1:100

CDT peers

Amgen Inc. logo

AMGN

Amgen Inc.

$439.33

+1.29%

Gilead Sciences, Inc. logo

GILD

Gilead Sciences, Inc.

$146.12

+1.87%

Vertex Pharmaceuticals Incorporated logo

VRTX

Vertex Pharmaceuticals Incorporated

$548.05

+1.44%

Intuitive Surgical, Inc. logo

ISRG

Intuitive Surgical, Inc.

$378.81

+1.16%

Sanofi logo

SNY

Sanofi

$45.85

+1.55%

Regeneron Pharmaceuticals, Inc. logo

REGN

Regeneron Pharmaceuticals, Inc.

$834.04

+0.90%

Continue in GoAI

Research CDT

research.disclaimer